| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/22/2007 | CA2618791A1 Novel mucin-type glycoprotein and use thereof |
| 02/22/2007 | CA2618773A1 Sulfate adenyltransferase gene and use thereof |
| 02/22/2007 | CA2618740A1 Selective vpac2 receptor peptide agonists |
| 02/22/2007 | CA2618734A1 Fusion proteins between plant cell-wall degrading enzymes, and their uses |
| 02/22/2007 | CA2618476A1 Albumin fusion proteins |
| 02/22/2007 | CA2618198A1 Isolation of the t-complex distorters and applications thereof |
| 02/22/2007 | CA2618066A1 Differentially protected orthogonal lanthionine technology |
| 02/22/2007 | CA2617734A1 Dihydroxy-acid dehydratase gene and use thereof |
| 02/22/2007 | CA2617649A1 Hybrid polypeptides with selectable properties |
| 02/22/2007 | CA2601869A1 Method for identifying target protein of agent and method for screening therapeutic agent for diabetes using target protein |
| 02/21/2007 | EP1754789A2 Bacillus strains and pesticidal proteins |
| 02/21/2007 | EP1754788A2 Prostate-specific membrane antigen and uses thereof |
| 02/21/2007 | EP1754786A2 Herbicide resistant products based on structure-based method |
| 02/21/2007 | EP1754784A2 Method for producing a heterologous secreted protein from chinese hamster ovary cells grown on microcarriers |
| 02/21/2007 | EP1754719A2 Anti-osteopontin antibody and use thereof |
| 02/21/2007 | EP1754718A2 Inactivation resistant factor VIII |
| 02/21/2007 | EP1754717A1 Antigenic peptides and their use |
| 02/21/2007 | EP1754716A1 Extreme thermophile single-stranded DNA binding mutant protein, and nucleic acid isothermal amplification method of use thereof |
| 02/21/2007 | EP1754715A1 Vaccine on the basis of virus-neutralising antibodies |
| 02/21/2007 | EP1754713A1 apo2l (trail) receptor binding peptides and uses thereof |
| 02/21/2007 | EP1754492A1 Novel drug discovery target and medicine acting on the same |
| 02/21/2007 | EP1754487A1 Modulators of the Melted protein and uses thereof |
| 02/21/2007 | EP1754485A1 Remedy for neurodegenerative diseases |
| 02/21/2007 | EP1753875A2 Genetic polymorphisms associated with vascular diseases, methods of detection and uses thereof |
| 02/21/2007 | EP1753871A2 Antibodies and related molecules that bind to psca proteins |
| 02/21/2007 | EP1753866A2 Plastid transit peptides |
| 02/21/2007 | EP1753865A2 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 02/21/2007 | EP1753864A2 Taste receptors of the t1r family from domestic dog |
| 02/21/2007 | EP1753845A2 Fixed bed hydroprocessing methods and systems and methods for upgrading an existing fixed bed system |
| 02/21/2007 | EP1753783A2 Anti-cd3 antibodies and methods of use thereof |
| 02/21/2007 | EP1753782A1 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 02/21/2007 | EP1753781A1 Peptides or peptidic conjugate derivatives of msh and the use thereof for cosmetically fighting against canities |
| 02/21/2007 | EP1753780A1 Selective vpac2 receptor peptide agonists |
| 02/21/2007 | EP1753779A2 Interferon-alpha polypeptides and conjugates |
| 02/21/2007 | EP1753778A1 Method for purifying erythropoietin |
| 02/21/2007 | EP1753777A2 METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION USING TRIM5a |
| 02/21/2007 | EP1753454A1 Vaccine for periodontal disease |
| 02/21/2007 | EP1753450A1 Process for the isolation and/or purification of proteins |
| 02/21/2007 | EP1753448A2 Compositions comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 02/21/2007 | EP1753447A2 Immune response suppressor and treatment of multiple sclerosis |
| 02/21/2007 | EP1753442A2 Method of administering and using vegf inhibitors for the treatment of human cancer |
| 02/21/2007 | EP1753441A2 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/21/2007 | EP1753286A1 Plants having improved growth characteristics and a method for making the same |
| 02/21/2007 | EP1644480A4 Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 02/21/2007 | EP1608685B1 Vegf antagonists for the treatment of diabetes |
| 02/21/2007 | EP1592702A4 Beta-2 microglobulin (b2m) and b2m related gene products for the regulation of osteoarthritis pathogenesis and chondrocyte proliferation |
| 02/21/2007 | EP1532163A4 Androgen receptor coregulators |
| 02/21/2007 | EP1517913B1 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
| 02/21/2007 | EP1334365B1 Screening methods for bone morphogenetic mimetics |
| 02/21/2007 | EP1328546B1 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 02/21/2007 | EP1294912B1 Gtp binding stress-related protein and methods of its use in plants |
| 02/21/2007 | EP1290137B1 Virulence genes, proteins, and their use |
| 02/21/2007 | EP1280545B1 Cross-linked collagen matrices and methods for their preparation |
| 02/21/2007 | EP1232177B1 Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides |
| 02/21/2007 | EP1212438B8 Flax seed specific promoters |
| 02/21/2007 | EP1161524B1 CELLS COEXPRESSING AN AMYLOID PRECURSOR PROTEIN AND AN $g(a)-SECRETASE AND THEIR USES IN TEST METHODS AND DIAGNOSTICS |
| 02/21/2007 | EP1151307B1 Methods for differentiating and monitoring parathyroid and bone status related diseases |
| 02/21/2007 | EP1137812B1 Dna-protein fusions and uses thereof |
| 02/21/2007 | EP1135503B1 Drug targets in candida albicans |
| 02/21/2007 | EP1104438B1 Novel anti-diabetic peptides |
| 02/21/2007 | EP1100819B1 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 02/21/2007 | EP1086225B1 Human tumour-derived polypeptide hormone phosphatonin |
| 02/21/2007 | EP1086117B1 Cloning and identification of the motilin receptor |
| 02/21/2007 | EP1075521B1 Basb019 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 02/21/2007 | EP1003787B1 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 02/21/2007 | EP1000154B1 Identification of human cell lines for the production of human proteins by endogenous gene activation |
| 02/21/2007 | EP0999848B1 Chimeric proteins for the treatment of diabetes |
| 02/21/2007 | EP0954334B1 Use of macrophage migration inhibitory factor antagonists for anti-cancer therapy |
| 02/21/2007 | EP0894004B2 Method for enhancing functional recovery of motor coordination, speech or sensory perception after central nervous system ischemia or trauma |
| 02/21/2007 | EP0815202B1 Human tissue inhibitor of metalloproteinase-4 |
| 02/21/2007 | EP0602046B2 Detection of feline immunodeficiency viruses |
| 02/21/2007 | EP0590126B1 Polypeptides having kinase activity, their preparation and use |
| 02/21/2007 | CN1918301A Orotate transporter encoding marker genes |
| 02/21/2007 | CN1918299A Method for generating tethered proteins |
| 02/21/2007 | CN1918296A Toxin complex proteins and genes from xenorhabus bovienii |
| 02/21/2007 | CN1918290A Screening method |
| 02/21/2007 | CN1918285A System and method of up-regulating bone morphogenetic protein (bmp) gene expression in bone cells via the appplication of fields generated by specific and selective electric and electromagnetic signal |
| 02/21/2007 | CN1918281A Vaccine for periodontal disease |
| 02/21/2007 | CN1918177A Novel glp-1 compounds |
| 02/21/2007 | CN1918176A Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 02/21/2007 | CN1917902A Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/21/2007 | CN1917898A Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections |
| 02/21/2007 | CN1916172A Method for preparing parathormone 1-34 |
| 02/21/2007 | CN1916167A Modulation of peroxisome proliferation-activated receptors |
| 02/21/2007 | CN1916025A Analogs of parathyroid hormone |
| 02/21/2007 | CN1916024A Constructing mutant sequence of high relative quick alphd-2b interferon, expression plasmid of yeast, strain filtration, and purification method |
| 02/21/2007 | CN1916023A Polypeptide in small molecule of endothelium inhibin, nucleotide sequence for encoding the polypeptide and complementary strand |
| 02/21/2007 | CN1916022A Gene correlative to cardiovascular pathology caused by diabetes, and usage |
| 02/21/2007 | CN1916021A Amido glycoside of sea pearl oyster, prepartion method, and usage |
| 02/21/2007 | CN1916017A Process for producing hydrophobic polypeptides, proteins or peptides. |
| 02/21/2007 | CN1915425A Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/21/2007 | CN1915424A Acellular pertussis vaccines and methods of preparation thereof |
| 02/21/2007 | CN1301268C Thrombus-resolving and anticoagulation double function fusion protein and use thereof |
| 02/21/2007 | CN1301267C A simulated epitope peptide of MUC1 mucoprotein and its encoding DNA and use thereof |
| 02/21/2007 | CN1301266C High molecular wheat glutelin subunit, genes encoding and use thereof |
| 02/21/2007 | CN1301265C Synthesized polypeptide and application |
| 02/20/2007 | US7179973 Inbred corn line GS05-32431 |
| 02/20/2007 | US7179972 Plants and seeds of corn variety I006605 |
| 02/20/2007 | US7179965 Cry1F and Cry1Ac transgenic cotton lines and event-specific identification thereof |
| 02/20/2007 | US7179964 Transgenic plants with elevated thioredoxin levels |